Related Experiment Video
Updated: Aug 22, 2025

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1
Cuihong Jiang1, Lili He2, Shuai Xiao2
1Department of Head and Neck Radiotherapy (One), Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China. cuihongjiang0623@163.com.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) is a lethal malignancy. Given the essential roles of E3 ligases in cancer immunotherapies, this paper explored the effect of E3 ubiquitin ligase ring finger protein 125 (RNF125) on immune escape in HNSCC. After delivering overexpressed (oe)-RNF125, interferon-gamma, or oe-programmed death-ligand 1 (PD-L1) into HNSCC cells and cell culture with carboxyfluorescein succinimidyl ester-labeled CD8+ T cells, RNF125 and PD-L1 levels were determined via RT-qPCR and Western blot, with HNSCC cell behaviors assessed via colony formation assay, Transwell assays and flow cytometry, and inflammatory factors measured via ELISA. PD-L1 ubiquitination level and PD-L1's interaction with RNF125 were analyzed via co-immunoprecipitation. The in vivo action of RNF125 on HNSCC was validated via nude mouse tumorigenicity assay. Briefly, RNF125 was weakly expressed in HNSCC cells. RNF125 overexpression inhibited immune escape of HNSCC cells, evidenced by decreased TSCCA cell proliferation, migration, and invasion, increased CD8+ T cell proliferation, and elevated IL-2 and TNF-α levels. RNF125 downregulated PD-L1 in TSCCA cells and facilitated PD-L1 ubiquitinational degradation. PD-L1 overexpression partially abated RNF125-mediated suppression on TSCCA cell immune escape. Moreover, RNF125 suppressed tumorigenesis and tumor growth in vivo. Overall, RNF125 promoted PD-L1 ubiquitinational degradation, hence inhibiting immune escape in HNSCC.
Insights
Ring finger protein 125 (RNF125) inhibits immune escape in head and neck squamous cell carcinoma (HNSCC). Overexpressing RNF125 reduces tumor progression and enhances T cell response by degrading programmed death-ligand 1 (PD-L1).
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer mortality.
- E3 ubiquitin ligases play crucial roles in cancer immunotherapy, influencing immune evasion.
- The specific role of RNF125 in HNSCC immune escape remains largely unexplored.
Purpose of the Study:
- To investigate the effect of E3 ubiquitin ligase RNF125 on immune escape mechanisms in HNSCC.
- To elucidate the molecular interaction between RNF125 and programmed death-ligand 1 (PD-L1) in HNSCC.
Main Methods:
- Overexpression of RNF125 and PD-L1 in HNSCC cell lines.
- Assessment of HNSCC cell behaviors (proliferation, migration, invasion) and immune cell responses (CD8+ T cell proliferation, cytokine release).
- Analysis of PD-L1 ubiquitination, RNF125-PD-L1 interaction via co-immunoprecipitation, and in vivo tumor growth in nude mice.
Main Results:
- RNF125 expression was low in HNSCC cells.
- RNF125 overexpression inhibited HNSCC proliferation, migration, and invasion, while enhancing CD8+ T cell proliferation and inflammatory cytokine (IL-2, TNF-α) production.
- RNF125 downregulated PD-L1 by promoting its ubiquitination and degradation, thereby suppressing HNSCC immune escape and tumor growth in vivo.
Conclusions:
- RNF125 functions as a tumor suppressor in HNSCC by inhibiting immune escape.
- RNF125 antagonizes PD-L1 expression and function, representing a potential therapeutic target for HNSCC immunotherapy.
- Targeting RNF125 may enhance anti-tumor immunity in HNSCC patients.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Negative Regulator Molecules
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulation of Nuclear Protein Sorting